Ikonisys

About:

Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection.

Website: http://www.ikonisys.com

Top Investors: Goldman Sachs, New Science Ventures, Lakeview Capital Management, Palisade Capital Management, Trevi Health Ventures

Description:

Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease.

Total Funding Amount:

$49.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

1999-01-01

Contact Email:

questions(AT)ikonisys.com

Founders:

Michael Kilpatrick

Number of Employees:

51-100

Last Funding Date:

2024-11-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai